Milestone Pharmaceuticals Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Milestone Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Milestone Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$9.66M, a 41.2% increase year-over-year.
  • Milestone Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$49.3M, a 18.8% increase year-over-year.
  • Milestone Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$61.1M, a 2.44% decline from 2022.
  • Milestone Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$59.6M, a 38.5% decline from 2021.
  • Milestone Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$43.1M, a 15.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$61.1M -$1.46M -2.44% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$59.6M -$16.6M -38.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$43.1M +$7.64M +15.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 -$50.7M +$7.17M +12.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$57.9M -$34.1M -143% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 -$23.8M Jan 1, 2018 Dec 31, 2018 10-K/A 2020-10-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.